Akebia Therapeutics, Inc. (AKBA)

Akebia Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	137.31	51.87	42.93	90.47	149.8	228.7
Short-Term Investments	-	-	-	-	-	39.99
Cash & Short-Term Investments	137.31	51.87	42.93	90.47	149.8	268.69
Cash Growth	247.62%	20.84%	-52.55%	-39.61%	-44.25%	81.92%
Receivables	72.81	34.37	39.29	40.28	55.89	28.58
Inventory	16.71	16.24	15.69	21.57	36.63	61.02
Prepaid Expenses	-	4.03	14.49	15.62	28.83	12.76
Restricted Cash	-	-	-	-	-	0.4
Other Current Assets	7.83	7.32	5.75	17.25	-	-
Total Current Assets	234.66	113.83	118.15	185.18	271.15	371.44
Property, Plant & Equipment	7.7	10.42	16.05	34.37	40.61	35.5
Goodwill	59.04	59.04	59.04	59.04	59.04	55.05
Other Intangible Assets	-	-	36.04	72.08	108.13	144.17
Other Long-Term Assets	44.19	37.38	12.42	5.37	50.42	37.98
Total Assets	345.6	220.67	241.7	356.05	529.35	644.14
Accounts Payable	11.55	15.18	14.64	18.02	33.59	41.31
Accrued Expenses	59.14	33.27	42.94	53.92	97.51	125.34
Current Portion of Long-Term Debt	12.17	4.31	19.55	32	97.54	-
Current Portion of Leases	5.63	5.4	4.49	4.74	4.8	5.29
Current Unearned Revenue	5.53	-	-	3.74	20.91	15.21
Other Current Liabilities	24.69	22.75	18.26	17.12	6.7	-
Total Current Liabilities	118.72	80.91	99.87	129.54	261.05	187.15
Long-Term Debt	177.43	175.47	111.29	91.56	53.08	96.38
Long-Term Leases	0.67	3.55	8.95	28.96	33.7	24.62
Long-Term Unearned Revenue	-	-	43.3	43.3	21.47	25.35
Other Long-Term Liabilities	19.55	9.93	8.89	57.47	86.03	63.03
Total Liabilities	316.37	269.86	272.29	350.82	455.34	396.52
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	1,701	1,629	1,578	1,562	1,537	1,425
Retained Earnings	-1,672	-1,678	-1,609	-1,557	-1,463	-1,178
Comprehensive Income & Other	0.01	0.01	0.01	0.01	0.01	0.01
Shareholders' Equity	29.22	-49.19	-30.58	5.23	74.01	247.62
Total Liabilities & Equity	345.6	220.67	241.7	356.05	529.35	644.14
Total Debt	195.9	188.73	144.28	157.27	189.13	126.29
Net Cash (Debt)	-58.59	-136.86	-101.35	-66.8	-39.33	142.41
Net Cash Growth	-	-	-	-	-	261.69%
Net Cash Per Share	-0.25	-0.65	-0.54	-0.37	-0.24	1.03
Filing Date Shares Outstanding	265.15	236.23	209.37	184.25	181.23	153.5
Total Common Shares Outstanding	263.04	224.85	194.58	184.14	177	148.07
Working Capital	115.94	32.92	18.28	55.65	10.1	184.29
Book Value Per Share	0.11	-0.22	-0.16	0.03	0.42	1.67
Tangible Book Value	-29.82	-108.23	-125.67	-125.9	-93.16	48.4
Tangible Book Value Per Share	-0.11	-0.48	-0.65	-0.68	-0.53	0.33
Machinery	-	-	-	-	5.85	5.79
Leasehold Improvements	-	-	-	-	8.57	8.57

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q